Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
83

Summary

Conditions
  • Cancer
  • Neuroblastoma
Type
Interventional
Phase
Phase 1
Design
Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 1 years and 21 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02780128
Collaborators
  • Novartis Pharmaceuticals
  • Foundation Medicine
Investigators
Principal Investigator: Yael P Mossé, MD Children's Hospital of Philadelphia, The University of Pennsylvania Principal Investigator: John M Maris, MD Children's Hospital of Philadelphia, The University of Pennsylvania